1. Catalogs
  2. ViennaLab Diagnostics
  3. Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101

Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101

Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101

Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101

Product catalog summary
Introduction
Carbamazepine is an anticonvulsant used to treat epilepsy, bipolar disorder, and trigeminal neuralgia. However, it can cause adverse skin reactions in up to 10% of patients, ranging from mild to severe conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which have high mortality rates.
HLA Alleles and Hypersensitivity
The HLA-A*31:01 allele is linked to carbamazepine-induced hypersensitivity reactions in Europeans and Japanese, while HLA-B*15:02 is associated with severe reactions in many Asian populations. Testing for these alleles before treatment can reduce the risk of severe hypersensitivity.
RealFast™ Assays
The ViennaLab HLA-A3101 and HLA-B1502 RealFast™ Assays are designed for real-time PCR testing to detect these alleles. The assays include positive and negative controls and are compatible with various PCR instruments and the ViennaLab D2PCR™ Buffer for rapid DNA isolation.
Procedure and Compatibility
The D2PCR™ Buffer simplifies the preparation of PCR templates, allowing for quick processing and compatibility with multiple RealFast™ Assays. When used with ultrafast cycling on instruments like the MIC qPCR Cycler, results can be obtained in under an hour.
Conclusion
Implementing these assays in clinical settings can significantly reduce the incidence of carbamazepine-induced hypersensitivity by identifying at-risk patients before treatment.
See more

Catalog excerpts

Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101-1

i=rsjrsj/\/\5 ESTABLISHED INNOVATIONS IN DIAGNOSTICS Carbamazepine HypersensitivityReal-time PCR assays for HLA-A*31:01 and HLA-B*15:02 to minimize the risk of oarbamazepine-induoed hypersensitivity reactions Carbamazepine, adverse reactions and HLA alleles Carbamazepine is an anticonvulsant commonly prescribed for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. Up to 10% of patients show cutaneous adverse reactions ranging from relatively mild maculopapular exanthema (MPE) to severe drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Although rare, DRESS, SJS and TEN show a high mortality rate of 10% to 50%. The human leukocyte antigen allele HLA-A*31:01 is predominantly associated with carbamazepine-induced MPE, DRESS and SJS/TEN in Europeans and Japanese. Also in Chinese, the allele is a risk factor for MPE and DRESS. Another HLA allele, HLA-B*15:02, is strongly associated with carbamazepine-induced SJS/TEN in many Asian populations, where the prevalence of the allele can be up to 25%. According to the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines, patients positive for HLA-A*31:01 or HLA-B*15:02 should not be treated with carbamazepine. Thus, testing of patients prior to starting therapy will significantly reduce the incidence of severe hypersensitivity reactions. ViennaLab HLA-A3101 and HLA-B1502 RealFast™ Assays • Single reaction per sample (PCR control included) • Easy interpretation of results: signal for HLA-A*31:01 or HLA-B*15:02 present or absent • Positive and negative controls supplied with the kit • Compatible with ViennaLab D2PCR™ Buffer for rapid DNA isolation • Compatible with a wide range of real-time PCR instruments C € IIVDl REF: • HLA-A3101 RealFast™ Assay: 7-640/7-643 (100/32 reactions) • HLA-B1502 RealFast™ Assay: 7-630/7-633 (100/32 reactions)

 Open the catalog to page 1
Carbamazepine Hypersensitivity - HLA-B1502/HLA-A3101-2

i=rsjrsj/\/\5 ESTABLISHED INNOVATIONS IN DIAGNOSTICS Carbamazepine (CBZ) hypersensitivity in different populations HLA allele Abbreviations: MPE, maculopapular exanthema; DRESS, severe drug reaction with eosinophilia and systemic symptoms; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis D2PCR™ Buffer for an even faster workflow of RealFast™ Assays The D2PCR™ Buffer is designed to offer a rapid and simple protocol for generating ready-to-use PCR templates. These templates can be directly used for the subsequent PCR without any further processing of the DNA. The D2PCR™ Buffer is...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.